LANTHANUM CATION (3+) Pharmacologic Class Indexing
- Class set ID
- 71dc498f-7f3a-4c80-aeb6-c9fd3bb40c8b
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use LANTHANUM CARBONATE safely and effectively. See full prescribing information for LANTHANUM CARBONATE. LANTHANUM CARBONATE chewable tablets, for oral use Initial U.S. Approval: 2004 | Prasco Laboratories | Patheon Manufacturing Services LLC | Element Materials Technology Pharma US LLC | Reading Scientific Services Ltd (RSSL) | Triclinic Labs | Microbac Laboratories, Inc. | Reckitt Benckiser Healthcare International Ltd. | 20251215 | 10 |
| These highlights do not include all the information needed to use LANTHANUM CARBONATE CHEWABLE TABLETS safely and effectively. See full prescribing information for LANTHANUM CARBONATE CHEWABLE TABLETS. LANTHANUM CARBONATE chewable tablets, for oral use Initial U.S. Approval: 2004 | Ascend Laboratories, LLC | Alkem Laboratories Limited | 20250506 | 15 |
| These highlights do not include all the information needed to use LANTHANUM CARBONATE CHEWABLE TABLETS safely and effectively. See full prescribing information for LANTHANUM CARBONATE CHEWABLE TABLETS . LANTHANUM CARBONATE chewable tablets, for oral use Initial U.S. Approval: 2004 | Teva Pharmaceuticals USA, Inc. | 20250130 | 8 |
| These highlights do not include all the information needed to use FOSRENOL safely and effectively. See full prescribing information for FOSRENOL. FOSRENOL ® (lanthanum carbonate) chewable tablets, for oral use FOSRENOL ® (lanthanum carbonate) oral powder, for oral use Initial U.S. Approval: 2004 | Takeda Pharmaceuticals America, Inc. | Patheon Manufacturing Services LLC | Element Materials Technology Pharma US LLC | Reading Scientific Services Ltd (RSSL) | Triclinic Labs | Microbac Laboratories, Inc. | Catalent Germany Schorndorf GmbH | BCM Ltd | Reckitt Benckiser Healthcare International Ltd. | 20241231 | 58 |
| These highlights do not include all the information needed to use LANTHANUM CARBONATE CHEWABLE TABLETS safely and effectively. See full prescribing information for LANTHANUM CARBONATE CHEWABLE TABLETS. LANTHANUM CARBONATE Chewable Tablets, for oral use Initial U.S. Approval: 2004 | Lupin Pharmaceuticals, Inc. | NATCO PHARMA LIMITED | Natco Pharma Limited-Pharma Division | 20241107 | 16 |
| These highlights do not include all the information needed to use LANTHANUM CARBONATE CHEWABLE TABLETS safely and effectively. See full prescribing information for LANTHANUM CARBONATE CHEWABLE TABLETS. LANTHANUM CARBONATE chewable tablets, for oral use Initial U.S. Approval: 2004 | Exelan Pharmaceuticals, Inc. | InvaGen Pharmaceuticals, Inc. | Genvion Corporation | 20240801 | 4 |
| These highlights do not include all the information needed to use LANTHANUM CARBONATE CHEWABLE TABLETS safely and effectively. See full prescribing information for LANTHANUM CARBONATE CHEWABLE TABLETS. LANTHANUM CARBONATE chewable tablets, for oral use Initial U.S. Approval: 2004 | Cipla USA Inc. | InvaGen Pharmaceuticals, Inc. | Genvion Corporation | 20240801 | 4 |